The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
about
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
@en
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
@nl
type
label
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
@en
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
@nl
prefLabel
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
@en
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer
@en
P2093
Naisi Huang
Sheng Huang
Zhiming Shao
P2860
P304
14951-14962
P356
10.18632/ONCOTARGET.7498
P407
P577
2016-02-19T00:00:00Z